NRx Pharmaceuticals, Inc.

NasdaqCM:NRXP Stock Report

Market Cap: US$116.6m

NRx Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NRXP?
Owner TypeNumber of SharesOwnership Percentage
Private Companies963,4802.92%
Individual Insiders1,782,5655.4%
Institutions3,264,6489.88%
Hedge Funds4,736,73714.3%
General Public22,287,30567.5%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 109.4%.

Top Shareholders

Top 25 shareholders own 32.37% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.08%
The B Group, Inc.
3,000,000US$10.6m0%6.14%
5.26%
Anson Group
1,736,737US$6.1m-42.9%0.52%
4.59%
Jonathan Javitt
1,516,634US$5.4m0%no data
4.03%
The Vanguard Group, Inc.
1,329,764US$4.7m82.2%no data
2.92%
Glytech, LLC
963,480US$3.4m0%no data
1.27%
AdvisorShares Investments, LLC
420,467US$1.5m28.2%0.17%
1.2%
Commonwealth Equity Services, LLC
397,431US$1.4m8.4%no data
0.94%
Geode Capital Management, LLC
310,112US$1.1m41.7%no data
0.67%
Chaim Hurvitz
221,480US$781.4k0%no data
0.35%
Bleakley Financial Group, LLC
117,204US$413.5k0%no data
0.3%
BlackRock, Inc.
98,995US$349.3k19.8%no data
0.26%
State Street Global Advisors, Inc.
86,984US$306.9k0%no data
0.24%
XTX Markets Limited
78,733US$277.8k0%no data
0.13%
Patrick Flynn
44,451US$156.8k0%no data
0.13%
Jane Street Group, LLC
44,152US$155.8k16%no data
0.13%
Northern Trust Global Investments
43,469US$153.4k50.2%no data
0.12%
Headlands Tech Holdings, LLC
39,394US$139.0k0%0.01%
0.12%
Global Retirement Partners, LLC
39,300US$138.7k0%no data
0.11%
One Wealth Management Investment and Advisory Services, LLC
37,873US$133.6k0%0.11%
0.1%
Chicago Partners Investment Group LLC
34,479US$121.6k3.17%no data
0.1%
AXQ Capital, LP
33,211US$117.2k0%0.01%
0.096%
Virtu Financial, Inc.
31,785US$112.1k0%no data
0.076%
UBS Asset Management AG
25,227US$89.0k613%no data
0.067%
FMR LLC
21,976US$77.5k0%no data
0.06%
Schonfeld Strategic Advisors LLC
19,876US$70.1k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/24 10:30
End of Day Share Price 2026/05/22 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

NRx Pharmaceuticals, Inc. is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC
Thomas ShraderBTIG
Jason KolbertD. Boral Capital LLC.